Literature DB >> 23011124

Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.

Shobha Phansalkar1, Heleen van der Sijs, Alisha D Tucker, Amrita A Desai, Douglas S Bell, Jonathan M Teich, Blackford Middleton, David W Bates.   

Abstract

OBJECTIVE: Alert fatigue represents a common problem associated with the use of clinical decision support systems in electronic health records (EHR). This problem is particularly profound with drug-drug interaction (DDI) alerts for which studies have reported override rates of approximately 90%. The objective of this study is to report consensus-based recommendations of an expert panel on DDI that can be safely made non-interruptive to the provider's workflow, in EHR, in an attempt to reduce alert fatigue.
METHODS: We utilized an expert panel process to rate the interactions. Panelists had expertise in medicine, pharmacy, pharmacology and clinical informatics, and represented both academic institutions and vendors of medication knowledge bases and EHR. In addition, representatives from the US Food and Drug Administration and the American Society of Health-System Pharmacy contributed to the discussions.
RESULTS: Recommendations and considerations of the panel resulted in the creation of a list of 33 class-based low-priority DDI that do not warrant being interruptive alerts in EHR. In one institution, these accounted for 36% of the interactions displayed. DISCUSSION: Development and customization of the content of medication knowledge bases that drive DDI alerting represents a resource-intensive task. Creation of a standardized list of low-priority DDI may help reduce alert fatigue across EHR.
CONCLUSIONS: Future efforts might include the development of a consortium to maintain this list over time. Such a list could also be used in conjunction with financial incentives tied to its adoption in EHR.

Entities:  

Mesh:

Year:  2012        PMID: 23011124      PMCID: PMC3628052          DOI: 10.1136/amiajnl-2012-001089

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  24 in total

1.  Preventable medication errors: identifying and eliminating serious drug interactions.

Authors:  J F Peterson; D W Bates
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

2.  ORCA: OpeRational ClassificAtion of drug interactions.

Authors:  P D Hansten; J R Horn; T K Hazlet
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

3.  Comparison of two knowledge bases on the detection of drug-drug interactions.

Authors:  G Del Fiol; B H Rocha; G J Kuperman; D W Bates; P Nohama
Journal:  Proc AMIA Symp       Date:  2000

Review 4.  What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior?

Authors:  Angela Schedlbauer; Vibhore Prasad; Caroline Mulvaney; Shobha Phansalkar; Wendy Stanton; David W Bates; Anthony J Avery
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

5.  Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication error reductions.

Authors:  Heleen van der Sijs; Laureen Lammers; Annemieke van den Tweel; Jos Aarts; Marc Berg; Arnold Vulto; Teun van Gelder
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

6.  Performance of community pharmacy drug interaction software.

Authors:  T K Hazlet; T A Lee; P D Hansten; J R Horn
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

7.  Physician versus computer knowledge of potential drug interactions in the emergency department.

Authors:  M I Langdorf; J C Fox; R S Marwah; B J Montague; M M Hart
Journal:  Acad Emerg Med       Date:  2000-11       Impact factor: 3.451

8.  Clinicians' assessments of electronic medication safety alerts in ambulatory care.

Authors:  Saul N Weingart; Brett Simchowitz; Lawrence Shiman; Daniela Brouillard; Adrienne Cyrulik; Roger B Davis; Thomas Isaac; Michael Massagli; Laurinda Morway; Daniel Z Sands; Justin Spencer; Joel S Weissman
Journal:  Arch Intern Med       Date:  2009-09-28

9.  Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.

Authors:  Balthasar L Hug; Daniel J Witkowski; Colin M Sox; Carol A Keohane; Diane L Seger; Catherine Yoon; Michael E Matheny; David W Bates
Journal:  J Gen Intern Med       Date:  2009-11-06       Impact factor: 5.128

Review 10.  Advancing clinical decision support using lessons from outside of healthcare: an interdisciplinary systematic review.

Authors:  Helen W Wu; Paul K Davis; Douglas S Bell
Journal:  BMC Med Inform Decis Mak       Date:  2012-08-17       Impact factor: 2.796

View more
  75 in total

1.  Trends in biomedical informatics: automated topic analysis of JAMIA articles.

Authors:  Dong Han; Shuang Wang; Chao Jiang; Xiaoqian Jiang; Hyeon-Eui Kim; Jimeng Sun; Lucila Ohno-Machado
Journal:  J Am Med Inform Assoc       Date:  2015-11       Impact factor: 4.497

2.  Promoting the Shared-Care Model for Adolescent and Young Adults With Cancer: Optimizing Referrals and Care Coordination With Primary Care Providers.

Authors:  Karen E Kinahan; Sheetal Kircher; Jessica Altman; Alfred Rademaker; John M Salsman; Aarati Didwania; Bridget O'Brien; Alpa C Patel; Stacy D Sanford
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

3.  Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward.

Authors:  Pieter Cornu; Stephane Steurbaut; Sabina Soštarić; Aleš Mrhar; Alain G Dupont
Journal:  Int J Clin Pharm       Date:  2014-02-25

4.  Integrity of clinical information in computerized order requisitions for diagnostic imaging.

Authors:  Ronilda Lacson; Romeo Laroya; Aijia Wang; Neena Kapoor; Daniel I Glazer; Atul Shinagare; Ivan K Ip; Sameer Malhotra; Keith Hentel; Ramin Khorasani
Journal:  J Am Med Inform Assoc       Date:  2018-12-01       Impact factor: 4.497

5.  The tradeoffs between safety and alert fatigue: Data from a national evaluation of hospital medication-related clinical decision support.

Authors:  Zoe Co; A Jay Holmgren; David C Classen; Lisa Newmark; Diane L Seger; Melissa Danforth; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2020-08-01       Impact factor: 4.497

6.  Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Authors:  S M M Meslin; W Y Zheng; R O Day; E M Y Tay; M T Baysari
Journal:  Appl Clin Inform       Date:  2018-11-28       Impact factor: 2.342

7.  Provider use of and attitudes towards an active clinical alert: a case study in decision support.

Authors:  J Feblowitz; S Henkin; J Pang; H Ramelson; L Schneider; F L Maloney; A R Wilcox; D W Bates; A Wright
Journal:  Appl Clin Inform       Date:  2013-03-27       Impact factor: 2.342

8.  A retrospective analysis of interruptive versus non-interruptive clinical decision support for identification of patients needing contact isolation.

Authors:  J M Pevnick; X Li; J Grein; D S Bell; P Silka
Journal:  Appl Clin Inform       Date:  2013-12-04       Impact factor: 2.342

9.  Toward a complete dataset of drug-drug interaction information from publicly available sources.

Authors:  Serkan Ayvaz; John Horn; Oktie Hassanzadeh; Qian Zhu; Johann Stan; Nicholas P Tatonetti; Santiago Vilar; Mathias Brochhausen; Matthias Samwald; Majid Rastegar-Mojarad; Michel Dumontier; Richard D Boyce
Journal:  J Biomed Inform       Date:  2015-04-24       Impact factor: 6.317

10.  A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.

Authors:  Manel Pladevall; George Divine; Karen E Wells; Ken Resnicow; L Keoki Williams
Journal:  Diabetes Educ       Date:  2014-12-08       Impact factor: 2.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.